These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
812 related articles for article (PubMed ID: 27896660)
1. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015. Heise CW; Brooks DE J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660 [TBL] [Abstract][Full Text] [Related]
2. 2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report. Mowry JB; Spyker DA; Brooks DE; McMillan N; Schauben JL Clin Toxicol (Phila); 2015; 53(10):962-1147. PubMed ID: 26624241 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127 [TBL] [Abstract][Full Text] [Related]
4. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report. Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763 [TBL] [Abstract][Full Text] [Related]
5. 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report. Mowry JB; Spyker DA; Brooks DE; Zimmerman A; Schauben JL Clin Toxicol (Phila); 2016 Dec; 54(10):924-1109. PubMed ID: 28004588 [TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay. Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498 [TBL] [Abstract][Full Text] [Related]
7. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Hamill J; Hallak J; Dursun SM; Baker G Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418 [TBL] [Abstract][Full Text] [Related]
8. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Gummin DD; Mowry JB; Spyker DA; Brooks DE; Fraser MO; Banner W Clin Toxicol (Phila); 2017 Dec; 55(10):1072-1252. PubMed ID: 29185815 [TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. McKenna DJ; Towers GH; Abbott F J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171 [TBL] [Abstract][Full Text] [Related]
10. Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063 [TBL] [Abstract][Full Text] [Related]
11. Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context. Lanaro R; Mello SM; da Cunha KF; Silveira G; Corrêa-Neto NF; Hyslop S; Cabrices OG; Costa JL; Linardi A Drug Test Anal; 2021 Mar; 13(3):664-678. PubMed ID: 33119972 [TBL] [Abstract][Full Text] [Related]
12. 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report. Mowry JB; Spyker DA; Cantilena LR; Bailey JE; Ford M Clin Toxicol (Phila); 2013 Dec; 51(10):949-1229. PubMed ID: 24359283 [TBL] [Abstract][Full Text] [Related]
13. Ayahuasca: What Healthcare Providers Need to Know. Goldin D; Salani D J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770 [TBL] [Abstract][Full Text] [Related]
14. 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Giffin SL Clin Toxicol (Phila); 2010 Dec; 48(10):979-1178. PubMed ID: 21192756 [TBL] [Abstract][Full Text] [Related]
15. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Dart RC Clin Toxicol (Phila); 2011 Dec; 49(10):910-41. PubMed ID: 22165864 [TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119 [TBL] [Abstract][Full Text] [Related]
17. Ayahuasca Alters Structural Parameters of the Rat Aorta. Pitol DL; Siéssere S; Dos Santos RG; Rosa ML; Hallak JE; Scalize PH; Pereira BF; Iyomasa MM; Semprini M; Riba J; Regalo SC J Cardiovasc Pharmacol; 2015 Jul; 66(1):58-62. PubMed ID: 25714595 [TBL] [Abstract][Full Text] [Related]
18. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Giffin SL Clin Toxicol (Phila); 2009 Dec; 47(10):911-1084. PubMed ID: 20028214 [TBL] [Abstract][Full Text] [Related]
19. Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users. Mello SM; Soubhia PC; Silveira G; Corrêa-Neto NF; Lanaro R; Costa JL; Linardi A J Psychoactive Drugs; 2019; 51(1):3-11. PubMed ID: 30582439 [TBL] [Abstract][Full Text] [Related]
20. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]